Acrivon Therapeutics, Inc. Common Stock (ACRV) vs SkinHealth Systems Inc. (SKIN)

A side-by-side comparison of Acrivon Therapeutics, Inc. Common Stock and SkinHealth Systems Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — ACRV vs SKIN

growth of $100 · dividends reinvested · last 4y
ACRV -88.1% (-41.3%/yr)SKIN -94.1% (-50.8%/yr)ACRV compounded faster over this window
050100150Start $1002023202420252026$12$6
ACRV SKIN

ACRV vs SKIN: by the numbers

  • •ACRV is the larger company ($79M vs $76M market cap).
  • •Both run net losses; ACRV's is the smaller (0.00% vs -9.79% net margin).

Metrics side by side

Valuation

MetricACRVSKIN
P/S ratioN/A0.26
P/B ratio0.911.36
EV / EBITDAN/A10.31
FCF yieldN/A21.95%

Profitability

MetricACRVSKIN
Gross margin0.00%66.34%
Operating margin0.00%-1.49%
Net margin0.00%-9.79%
ROE-85.65%-51.09%
ROIC-88.28%-1.02%

Growth (annualized)

MetricACRVSKIN
Revenue CAGR (5Y)N/A9.24%
Total return CAGR (5Y)N/A-53.07%

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.